Iridex outlines further cost reductions and targets profitability in 2025 as Q2 revenue rises 14% sequentially
Source: SeekingAlpha
2025-08-12 21:10:31 ET
More on IRIDEX
- IRIDEX Corporation (IRIX) Q2 2025 Earnings Call Transcript
- Financial information for IRIDEX
Read the full article on Seeking Alpha
For further details see:
Iridex outlines further cost reductions and targets profitability in 2025 as Q2 revenue rises 14% sequentially
IRIDEX Corporation
NASDAQ: IRIX
IRIX Trading
-3.53% G/L:
$1.2734 Last:
3,201 Volume:
$1.31 Open:
IRIX Latest News
March 12, 2026 04:05:00 pm
Iridex to Report Fourth Quarter and Full Year 2025 Financial Results on March 26, 2026
February 05, 2026 11:04:26 am
IRIX Price Target Alert: $3.00. Issued by Industrial Alliance Securities
January 12, 2026 09:38:49 am
Morning Market Pulse: From Clinical Crossroads to Capital Discipline, a Market Sorting Signal Emerges
IRIX Stock Data
$25,097,372
10,831,407
2.71%
10
N/A
Medical Equipment & Supplies
Healthcare
US
Mountain View
